PDGFRB and Alzheimer disease: The numbers of PDGFRβ-positive PEs, PE coverage of the capillary, and the number of capillaries are all reduced in the AD patient brain, which shows evidence of a gene-dose effect associated with the number of APOE4 alleles (Sengillo et al., 2013).